Skip to content

BHIVA: 60% increase in drug-resistant gonorrhoea amongst UK gay men last year, HIV-positive men disproportionately affected

BHIVA: Late diagnosis responsible for at least a quarter of HIV deaths, testing implications discussed

BHIVA: One-in-three UK HIV deaths 'not directly related to HIV'

Continuing 3TC therapy after viral rebound shows no benefit

Two-drug maintenance with tenofovir-efavirenz less effective than triple therapy

Darunavir response did not differ by prior PI in POWER studies

Reduced dose of Kaletra soft-gel capsule effective in small study (corrected)

Immunologically discordant response to HIV therapy associated with increased risk of disease progression

Darunavir: negative interactions with Kaletra, Viagra and contraceptive pill reported